Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,121
Total Claims
$1.2M
Drug Cost
1,139
Beneficiaries
$1,071
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
+47%
Opioid rate vs peers
3.8% vs 2.6% avg
-13%
Cost per patient vs peers
$1,071 vs $1,237 avg
+44%
Brand preference vs peers
13.3% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.8%
Opioid Rate
571
Opioid Claims
$15K
Opioid Cost
5.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,990 claims · $917K
Generic: 13,023 claims · $295K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 216 | $148K |
| Mirabegron | 97 | $74K |
| Insulin Glargine,hum.Rec.Anlog | 106 | $42K |
| Empagliflozin | 90 | $41K |
| Vibegron | 78 | $30K |
| Dapagliflozin Propanediol | 43 | $27K |
| Liraglutide | 12 | $27K |
| Fluticasone/Umeclidin/Vilanter | 36 | $26K |
| Rivaroxaban | 41 | $25K |
| Insulin Aspart | 49 | $25K |
| Dulaglutide | 23 | $22K |
| Sitagliptin Phosphate | 14 | $19K |
| Umeclidinium Brm/Vilanterol Tr | 30 | $19K |
| Semaglutide | 17 | $18K |
| Tiotropium Br/Olodaterol Hcl | 31 | $18K |
Prescribing Profile
Patient Profile
80
Avg Age
71%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About